Preoperative blood transfusions for sickle cell disease

Area of Science:

• Hematology
• Surgical Medicine
• Genetics

Background:

• Sickle cell disease (SCD) is a prevalent inherited disorder causing hemolytic anemia and organ dysfunction.
• Surgical interventions are frequently necessary for individuals with SCD.
• Preoperative blood transfusions aim to improve oxygen transport and reduce sickling complications.

Purpose of the Study:

• To evaluate the comparative risks and benefits of preoperative blood transfusion protocols in patients with sickle cell disease undergoing surgery.
• To synthesize evidence from randomized controlled trials on transfusion strategies for SCD patients.
• To inform clinical decision-making regarding perioperative care in SCD.

Main Methods:

• Systematic review of randomized and quasi-randomized controlled trials.
• Searched the Cochrane Cystic Fibrosis and Genetic Disorders Group Trials Register.
• Two studies involving 920 participants were included after assessing risk of bias and data extraction.

Main Results:

• A conservative transfusion regimen was as effective as an aggressive one in preventing perioperative complications for elective surgeries.
• The conservative approach resulted in fewer transfusion-related adverse events.
• One study found no advantage of preoperative transfusion over standard care.

Conclusions:

• Conservative preoperative transfusion therapy appears as effective as aggressive therapy for sickle cell disease patients.
• Optimal transfusion regimens require further investigation for different surgical contexts.
• The necessity of preoperative transfusion in all surgical scenarios warrants additional research.